Letters

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 | Next

Letter Items 1 - 5 of 80

AHA, Heatlh Organizations to Genentech, Inc. Re: Avastin, Herceptin and Rituxan

October 28, 2014

AHA, other health organizations urge Genentech to reconsider recent decision to remove three lifesaving cancer drugs  Avastin, Herceptin and Rituxan  from the traditional distribution channel in favor of specialty distributors. Learn More

AHA to Rep. Michael Burgess, M.D. Expressing Support for H.R. 5539

October 17, 2014

AHA to Rep. Michael Burgess, M.D. Expressing Support for H.R. 5539 Learn More

Senate Dear Colleague to CMS Re: Rulemaking Process and Its Impact on Rural Health Care Providers

October 09, 2014

Senate dear colleague letter to CMS regarding the CMS rulemaking process and its impact on rural health care providers. Learn More

AHA and others to DEA re: Disposal of Controlled Substances Final Rule published September 9, 2014

October 06, 2014

Groups urge urge DEA to delay the effective date of October 9, 2014 for provisions in Learn More

CMS Responds to Hospitals' Concerns About New QIO Contractors

September 30, 2014

CMS responds to hospitals concerns about new QIO contractors Learn More

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 | Next

About AHA

Membership

Member Constituency Sections

Key Relationships

News Center

Performance Improvement

Advocacy Issues

Products & Services

Publications

Research & Trends

Locations

155 N. Wacker Dr.
Chicago, Illinois 60606
312.422.3000

800 10th Street, N.W.
Two CityCenter, Suite 400
Washington, DC 20001-4956
202.638.1100

1.800.424-4301